TY - JOUR T1 - How Effective Is Endovascular Intracranial Revascularization in Stroke Prevention? Results from Borgess Medical Center Intracranial Revascularization Registry JF - American Journal of Neuroradiology JO - Am. J. Neuroradiol. SP - 1227 LP - 1231 DO - 10.3174/ajnr.A2670 VL - 32 IS - 7 AU - F. Al-Ali AU - T. Cree AU - L. Duan AU - S. Hall AU - A. Jefferson AU - S. Louis AU - K. Major AU - S. Smoker AU - S. Walker Y1 - 2011/08/01 UR - http://www.ajnr.org/content/32/7/1227.abstract N2 - BACKGROUND AND PURPOSE: The WASID study established the risk of subsequent ischemic stroke at 1 year in subjects with symptomatic intracranial atherosclerotic stenosis (70%–99%) at 18%. The efficacy of different methods of endovascular revascularization in stroke prevention still has not been established. We compared the stroke rate in our registry at 1 year following intervention with the WASID results to identify which method, if any, provides the most benefit in stroke prevention. This result from the BMC-IRR follows a previously published article comparing stent placement and angioplasty outcomes. MATERIALS AND METHODS: We maintained a nonrandomized single-center single-operator registry of consecutive symptomatic patients who underwent endovascular intracranial revascularization. Data were collected prospectively and retrospectively and analyzed retrospectively. Patients were treated with angioplasty, BMS, or self-expanding WS. To make our data comparable with that in the WASID study, we selected patients with a single lesion of 50%–99% stenosis undergoing a single intervention. Data was collected on patients until symptom recurrence, repeat intervention, or 1 year postintervention, whichever occurred first. RESULTS: We found that 115 patients fit the inclusion criteria, with 38 angioplasty, 28 BMS, and 49 WS cases. For patients with 70%–99% stenosis, the overall probability of stroke at 1 year postintervention was 19.3%. The overall stroke probability per device, independent of clinical presentation, was 12.5% for angioplasty, 20.2% for BMS, and 24.1% for WS. CONCLUSIONS: Compared with the WASID data, angioplasty appears to have a lower stroke rate after 1 year than medical therapy alone. However, neither stent-placement arm compared favorably with the WASID results. ACAanterior cerebral arteryBAbasilar arteryBCC-IRRBorgess Medical Center Intracranial Revascularization RegistryBMSballoon-mounted stentBMTbest medical therapyCIconfidence intervalICAinternal carotid arteryMCAmiddle cerebral arterymRSmodified Rankin ScaleSAMMPRISStenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial StenosisSSYLVIAStenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial ArteriesTIAtransient ischemic attackVAvertebral arteryWASIDWarfarin-Aspirin Symptomatic Intracranial DiseaseWSWingspan stent ER -